Open AccessVirologic suppression and CD4 + cell count recovery after initiation of raltegravir or efavirenz-containing HIV treatment regimens
Author(s) -
J.K. Edwards,
S.R. Cole,
H.I. Hall,
W.C. Mathews,
R.D. Moore,
M.J. Mugavero,
J.J. Eron
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/gt9w-e346
Subject(s) - raltegravir , efavirenz , human immunodeficiency virus (hiv) , medicine , pharmacology , antiretroviral therapy , virology , viral load